Cardiology

Top Story

Tocilizumab shows positive results for giant cell arteritis in phase 3 trial

Tocilizumab shows positive results for giant cell arteritis in phase 3 trial
July 27, 2017

In a phase 3 trial, tocilizumab showed positive phase 3 trial results for patients with giant cell arteritis.

“The publication of these phase 3 results in The New England Journal of Medicine validates the significance of our considerable basic and clinical autoimmune disease research in medical practice,” Sandra Horning, MD, chief medical officer and head of Global Product Development, said in a press release from Genentech. “The data from the GiACTA supported the FDA approval of the first new treatment option for patients with [giant cell arteritis] GCA in more than 50 years, and we are committed to continuing to explore new treatment options for autoimmune diseases with significant unmet medical need.”

In the Journals

Collaborative quality measures improve hypertension scores

July 27, 2017
Partaking in a quality improvement collaborative consisting of consultations with health experts, webinars and links to resources led to better hypertension scores among…
In the Journals Plus

‘Diabetic hand’ may be marker for subclinical atherosclerosis

July 27, 2017
Adults with type 2 diabetes and limited joint mobility of the hand were more likely to have subclinical atherosclerosis, as measured by increased carotid plaque…
In the Journals

Novel catheter shows promise for drug delivery in infrapopliteal de novo, restenotic lesions

July 27, 2017
A novel delivery catheter was safe and effective for administration of paclitaxel in prevention of restenosis in infrapopliteal de novo and restenotic lesions, according…

Q&A: Misinformation drives nonadherence to statin therapy

July 27, 2017
Despite the CV benefits being well-documented, many patients are nonadherent to statin therapy. Although this is often attributed to adverse events, particularly…
More Headlines »
CME

The Patient with Uncontrolled Diabetes at High Risk for a Cardiovascular Event

No commercial support for this activity.

The 2015 AACE guidelines incorporate an integrated consideration of micro- and macrovascular risk (including…
More »
Video
Meeting News

VIDEO: Heart failure most deadly complication of type 2 diabetes

July 16, 2017
More »
Resource Centers
Heart in Diabetes

Heart in Diabetes

Video
Meeting News

VIDEO: Meeting offers `think tank’ of experts

July 15, 2017
More »
Advertisement
Advertisement